<table border="single" id="id_9a9acf75-6603-4cbd-8e14-15cebf6e269d" width="464.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_cc3df524-4799-49d1-bf1c-fc1fa4c468ff"> Table 9: Results of Drug Interaction Studies with Didanosine: Effects of Coadministered Drug on Didanosine Plasma AUC and C<sub>max</sub> Values</caption>
<col width="32.1%"></col>
<col width="27.6%"></col>
<col width="6.9%"></col>
<col width="16.2%"></col>
<col width="17.2%"></col>
<tfoot id="id_c7b74ebc-674c-4174-87ef-879402c10df3">
<tr>
<td align="left" colspan="5" stylecode="Lrule Botrule" valign="top">↑ Indicates increase.<br/>↓ Indicates decrease.<br/>↔ Indicates no change, or mean increase or decrease of less than 10%.</td>
</tr>
</tfoot>
<tbody>
<tr id="id_f1b440b8-eac0-4590-b9de-823592f6807e">
<td align="left" colspan="3" stylecode="Toprule" valign="top"></td>
<td align="center" colspan="2" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">% Change of Didanosine</content>
</paragraph>
<content stylecode="bold">Pharmacokinetic Parameters
                                    </content>
</td>
</tr>
<tr id="id_7f04b605-46e3-4c09-bea7-58cfff17b6f5">
<td align="left" colspan="3" stylecode="Botrule" valign="top">
<content stylecode="bold"> Drug                                               Didanosine Dosage            n </content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">AUC of Didanosine</content>
</paragraph>
<content stylecode="bold">(90% CI)</content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">C<sub>max</sub> of Didanosine</content>
</paragraph>
<content stylecode="bold">(90% CI)</content>
</td>
</tr>
<tr id="id_656bcbce-9e08-4f75-b7cd-58b31bfb0b52">
<td align="left" stylecode="Botrule" valign="top">
<paragraph>tenofovir, <footnote id="id-5ab8a671-5b25-4271-91c2-63c687ad9ab3">All studies conducted in healthy volunteers at least 60 kg with creatinine clearance of at least 60 mL/min.</footnote>, <footnote id="id-60869de1-f36e-472d-97a7-9eaa7b1a8484">Tenofovir disoproxil fumarate.</footnote> 300 mg</paragraph>
<paragraph> once daily with a light meal<footnote id="id-e3969f79-dff3-440b-bc2f-5c446dafb0a4">373 kcalories, 8.2 grams fat.</footnote>
</paragraph>
<paragraph>tenofovir, <footnoteref idref="id-5ab8a671-5b25-4271-91c2-63c687ad9ab3"></footnoteref>, <footnoteref idref="id-60869de1-f36e-472d-97a7-9eaa7b1a8484"></footnoteref> 300 mg</paragraph>
<paragraph> once daily with a light meal<footnoteref idref="id-e3969f79-dff3-440b-bc2f-5c446dafb0a4"></footnoteref>
</paragraph>
<paragraph>tenofovir, <footnoteref idref="id-5ab8a671-5b25-4271-91c2-63c687ad9ab3"></footnoteref>, <footnoteref idref="id-60869de1-f36e-472d-97a7-9eaa7b1a8484"></footnoteref> 300 mg</paragraph>
<paragraph> once daily with a light meal<footnoteref idref="id-e3969f79-dff3-440b-bc2f-5c446dafb0a4"></footnoteref>
</paragraph>
<paragraph>
<content stylecode="bold">methadone</content>, chronic</paragraph>maintenance dose</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>400 mg single dose</paragraph>
<paragraph>fasting 2 hours before tenofovir</paragraph>
<paragraph>400 mg single dose</paragraph>
<paragraph>with tenofovir and a light meal</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>with tenofovir and a light meal</paragraph>
<paragraph>250 mg single dose</paragraph>
<paragraph>with tenofovir and a light meal</paragraph>
<paragraph>325 mg single dose</paragraph>
<paragraph>with tenofovir and a light meal</paragraph>400 mg single dose</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>26</paragraph>
<paragraph>25</paragraph>
<paragraph>33</paragraph>
<paragraph>33</paragraph>
<paragraph>33</paragraph>15, 16
                                 </td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 48%</paragraph>
<paragraph>(31, 67%)</paragraph>
<paragraph>↑ 60%</paragraph>
<paragraph>(44, 79%)</paragraph>
<paragraph>↑ 16%</paragraph>
<paragraph>(6, 27%) <footnote id="id-80c7a90e-4beb-4929-ba45-a18038983a62">Compared with didanosine delayed-release capsules 250 mg administered alone under fasting conditions.</footnote>
</paragraph>
<paragraph>↔</paragraph>
<paragraph>(-13, 5%)<footnote id="id-10dd143c-98c0-4363-8575-6ee7308de271">Compared with didanosine delayed-release capsules 400 mg administered alone under fasting conditions.</footnote>
</paragraph>
<paragraph>↑ 13%</paragraph>
<paragraph>(3, 24%)<footnoteref idref="id-10dd143c-98c0-4363-8575-6ee7308de271"></footnoteref>
</paragraph>
<paragraph>↓ 17%</paragraph>(-29, -2%)</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 48%</paragraph>
<paragraph>(25, 76%)</paragraph>
<paragraph>↑ 64%</paragraph>
<paragraph>(41, 89%)</paragraph>
<paragraph>↓ 12%</paragraph>
<paragraph>(-25, 3%)<footnoteref idref="id-80c7a90e-4beb-4929-ba45-a18038983a62"></footnoteref>
</paragraph>
<paragraph>↓ 20%</paragraph>
<paragraph>(-32, -7%)<footnoteref idref="id-10dd143c-98c0-4363-8575-6ee7308de271"></footnoteref>
</paragraph>
<paragraph>↓ 11%</paragraph>
<paragraph>(-24, 4%)<footnoteref idref="id-10dd143c-98c0-4363-8575-6ee7308de271"></footnoteref>
</paragraph>
<paragraph>↓ 16%</paragraph>(-33, 4%)</td>
</tr>
</tbody>
</table>